Anti-epilepsy drug linked to higher rates of autism Pregnant women who use valproate, an anti-epilepsy drug that is used to avoid migraines and treat bipolar disorder also, could be putting their babies at improved risk of autism. A new study released in JAMA on April 24 showed that children of moms who utilized valproate during being pregnant had a five situations higher risk of having a child who was eventually diagnosed with an autism spectrum disorder compared with women who didn’t use the drug dapoxetine 60 mg . This is an important risk element and one that could be avoided or at least the chance low in women who won’t need to take this and may take another drug, Dr. Kimford Meador, a professor of neurology at Emory University in Atlanta, thought to Businessweek.
These drugs have already been linked to an increased risk of heart episodes and strokes, but no study has examined if they increase the risk of atrial fibrillation – a condition which is connected with an increased long term risk of stroke, heart failure, and death. So a team of researchers, led by Professor Henrik Toft S-rensen at Aarhus University Hospital in Denmark, used the Danish National Registry of Sufferers to identify 32,602 individuals with a first analysis of atrial fibrillation or flutter between 1999 and 2008. Each case was compared with 10 age group and sex-matched control sufferers randomly selected from the Danish human population.